Markets:

Overview

News

Currencies

International

Treasuries

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

0.9001 +0.0001 (+0.01%)

Delayed Quote Updated: 4:00 PM EST, Nov 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Allogene Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday ↗

May 04, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

The Latest Analyst Ratings for Allogene Therapeutics ↗

May 04, 2023

Via Benzinga

Recap: Allogene Therapeutics Q1 Earnings ↗

May 03, 2023

Via Benzinga

Where Allogene Therapeutics Stands With Analysts ↗

April 18, 2023

Via Benzinga

Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday ↗

April 25, 2023

U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

7 Short-Squeeze Stocks That Could Make You Rich ↗

April 13, 2023

Although moving against the grain presents its own distinct set of risks, these short-squeeze stocks may profit the contrarian.

Via InvestorPlace

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

7 Short-Squeeze Stocks That Could Explode in April ↗

March 30, 2023

Although these short-squeeze stocks attracted bearish attention justifiably, contrarian sentiment may see them jump higher.

Via InvestorPlace

10 Analysts Have This to Say About Allogene Therapeutics ↗

March 21, 2023

Via Benzinga

Allogene Therapeutics's Return On Capital Employed Insights ↗

March 03, 2023

Via Benzinga

What 10 Analyst Ratings Have To Say About Allogene Therapeutics ↗

March 02, 2023

Via Benzinga

Short Interest Update - Monday, March 27 ↗

March 27, 2023

Although equities broadly are starting the new week higher, the most heavily shorted stocks are trading lower today.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗

March 21, 2023

Via Benzinga

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

March 08, 2023

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

Via News Direct

Topics Economy

5 Analysts Have This to Say About Allogene Therapeutics ↗

January 24, 2023

Via Benzinga

Expert Ratings for Allogene Therapeutics ↗

January 06, 2023

Via Benzinga

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds? ↗

March 07, 2023

Cryoport Inc. (NASDAQ: CYRX) provides the life sciences industry with comprehensive supply chain solutions to support vital therapeutics.

Via Benzinga

Short Squeezes Have Returned in 2023 -- Here's Your Playbook ↗

February 08, 2023

We haven't seen moves like these in a couple of years, so here's what investors should know.

Via The Motley Fool

Why Allogene Therapeutics Shares Are Seeing Blue Skies Today ↗

January 24, 2023

Allogene Therapeutics Inc (NASDAQ: ALLO) shares are trading higher by 13.1% to $7.76 Tuesday morning after the company announced data from its Phase 1 UNIVERSAL trial of ALLO-715 has been published in...

Via Benzinga

Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 24, 2023

Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023 ↗

January 24, 2023

Via Benzinga

Yext, 1-800-Flowers.com And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

January 24, 2023

U.S. stock futures traded slightly lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

WWE, AMTD Digital And Some Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

January 06, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. AMTD Digital Inc. (NYSE: HKD) shares surged 118.8% to $65.54 in pre-market...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 05, 2023

On Thursday, 63 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023? ↗

December 22, 2022

Crispr and Vertex are working toward the first submissions for a CRISPR-based product.

Via Investor's Business Daily

Top 10 Highest Short Interest Stocks And 10 With Highest Cost To Borrow: Where Do Carvana, MicroStrategy, Fisker And AMC Rank? ↗

December 17, 2022

Investors often look for stocks with high short interest and a high cost to borrow, which could predict a potential short squeeze. New data shared by S3 Partners could signal which stocks investors are...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.